Best Biotech Stocks to Invest In 2016 Edition

Biotech stocks had an amazing first half of 2015, then a volatile downward trend the second half of the year. Remember that the biotech sector experienced its fifth year in a bull market, but appeared to be slowing down with the rest of the market in January 2016. Here are some key facts to consider for the coming year as to how to play the biotech sector. Biotech Bulls and Bears First, check some of the headlines from the financial press throughout last year to see who was on the money and who was way off, at least for short-term...

Read More

Biotechs Trending This Week: Medivation Inc. (MDVN)

Biotech stocks have been a fabulous to place your money in the last ten years. Most of us who have bought Medivation (MDVN) ten years ago who saw the potential for this company and its leadership when it was under a dollar a share has done well. Those of us, who bought shares early on can boast of massive gains today even though the stock peaked back in 2015. Since its old highs MDVN has pulled back although now it is retracing back up. MDVN has the potential to go past the old highs in 2015 based on new...

Read More

What’s Up Next? Biotech And Pharma Goals And Objectives For 2016

Investing in biotech is in today’s market a very solid investment, plain and simple; and that has been the case for a number of years.  Following are the goals and objectives of several big-ticket biotech organizations worth following in 2016. Biogen Inc. (BIIB) Many are very positive toward Biogen Inc, as far as stocks are concerned.  One of the reasons is because they lead the market in MS medication and really hit a home-run with Tecfidera recently.  There also a number of medications who are in the later stages of development and geared toward such conditions as Alzheimer’s disease,...

Read More

Grim News for Anavex Life Sciences Corp

  Shareholders of Anavex Life Sciences Corp are in for some bad news. The stock prices of the biotech fell more than 20% after the Securities and Exchange Commission subpoenaed it (gave it an investigation order) a week ago, on December 22nd  on what seems to be suspicion of insider trading. As of January 5, the stock price is down to $5.86 according to the NASDAQ Stock Market. The company revealed this grim news in the annual 10k report filing of the company’s financial performance, explaining that the SEC wants to investigate the internal affairs of the corporation, particularly regarding...

Read More

Biotech Stocks: Here’s Where the Money is: Chimerix Inc (NASDAQ:CMRX)

Even though the overall stock market dipped in 2015, it was a big year for biotech companies. Nine of the top ten hottest stocks of the year in terms of share price increase came from the biotech sector. Eagle Pharmaceuticals (EGRX) was the biggest gaining stock of the year, with an increase of nearly 500 percent. At the end of the year Chimerix (CMRX) took a huge nosedive, but is now garnering positive analyst sentiment for 2016. A Banner Year for Biotechs Aside from the explosive growth of EGRX, other massive movers in biotech for the year were Exelixis...

Read More